Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from M3 ( (JP:2413) ).
M3, Inc. announced the repurchase of 149,400 of its own common shares for a total of 358,058,600 yen during November 2025. This move is part of a broader share repurchase program authorized by the Board of Directors, allowing for the repurchase of up to 20 million shares or 20 billion yen, aimed at optimizing capital structure and potentially enhancing shareholder value.
The most recent analyst rating on (JP:2413) stock is a Buy with a Yen2965.00 price target. To see the full list of analyst forecasts on M3 stock, see the JP:2413 Stock Forecast page.
More about M3
M3, Inc. operates in the healthcare industry, providing medical-related services and solutions. The company is listed on the Tokyo Stock Exchange and focuses on leveraging technology to enhance healthcare services.
YTD Price Performance: 86.82%
Average Trading Volume: 3,450,613
Technical Sentiment Signal: Hold
Current Market Cap: Yen1750B
Learn more about 2413 stock on TipRanks’ Stock Analysis page.